Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 19,600
- Avg volume
- 21,916
- Day's range
- $0.04 – $0.06
- Shares out
- —
- Stochastic %K
- 18%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was...
Show more
Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. was incorporated in 2015 and is based in San Diego, California.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- Phone
- 858 203 0312
- Website
- https://qgaicorp.com
- Address
- 15656 Bernardo Center Drive, Suite 801, San Diego, United States
Latest news
No headlines yet.
